(S)-Hydroxy-O-ethyl Des(boric Acid) Bortezomib is an intermediate in the synthesis of (S)-Hydroperoxy Des(boric Acid) Bortezomib (H715405), which is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.